CJ CheilJedang recorded Q1 2026 operating profit of $161M, down 28.5% year-over-year. (Source: DART consolidated financial statements — preliminary operating results fair disclosure, May 12, 2026)
Results at a Glance
Both revenue and operating profit declined year-over-year and quarter-over-quarter. Net income, however, swung to a profit from a large loss in the prior quarter and more than doubled compared to the same period last year.
- Revenue: $4.8B, -1.4% YoY, +1.5% QoQ
- Operating Profit: $161M, -28.5% YoY, -19.5% QoQ
- Operating Margin (Operating Profit / Revenue): ~3.3%
- Net Income: $81M (turned profitable from a $542M net loss in Q4 2025; +108.8% YoY)
- Net Income Attributable to Controlling Interests: $55M (turned profitable from a $557M loss in Q4 2025; +363.8% YoY)
Notes on Interpreting the Figures
The prior-year comparison figures (Q1 2025) disclosed in the filing have been restated due to accounting changes. The planned divestiture of the Brazilian subsidiary (CJ SELECTA and others) was withdrawn, prompting the resumption of previously suspended depreciation, while 14 subsidiaries in the Feed & Livestock (F&C) segment were reclassified as discontinued operations. As a result, the prior-year comparable revenue was restated from $4.9B to $4.5B, and operating profit from $226M to $195M. The year-over-year comparisons cited in the filing are based on the pre-restatement figures.
Market Reaction
Major outlets including Yonhap Infomax characterized the results as the bio segment "working through a trough." Opinion News highlighted the disconnect between K-Food growth momentum and the lack of a corresponding improvement in company-wide profitability. Additional market data such as share price and foreign ownership ratio were not included in this disclosure.
This article was auto-generated based on the original DART disclosure and domestic and international media reports. It is intended to deliver key data points promptly following the announcement. Readers are advised to review the company's official disclosure before making any investment decisions.
